931671366	931671366	CD	B-NP	O
|	|	NN	I-NP	O
SHR	SHR	NN	I-NP	O
|	|	NN	I-NP	O
06109053	06109053	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
171317	171317	CD	B-NP	O
|	|	CC	I-NP	O
6/13/2001	6/13/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
UROSEPSIS	UROSEPSIS	NNP	I-NP	O
,	,	,	O	O
MYOCARDIAL	MYOCARDIAL	NNP	B-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/13/2001	6/13/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2001	10/28/2001	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

BKA	BKA	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

E.	E.	NNP	B-NP	O
COLI	COLI	NNP	I-NP	O
UROSEPSIS	UROSEPSIS	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

NON-Q-WAVE	NON-Q-WAVE	JJ	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

MORBID	MORBID	NNP	B-NP	O
OBESITY	OBESITY	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
EDEMA	EDEMA	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

RULE	RULE	NN	B-NP	O
OUT	OUT	NN	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

OBSTRUCTIVE	OBSTRUCTIVE	NN	B-NP	O
SLEEP	SLEEP	NN	I-NP	O
APNEA	APNEA	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ACUTE	ACUTE	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
Daughters	Daughters	NNP	I-NP	O
Wyckwe	Wyckwe	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
46-year-old	46-year-old	JJ	I-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
BKA	BKA	NN	B-NP	B-protein
on	on	IN	B-PP	O
two	two	CD	B-NP	O
prior	prior	JJ	I-NP	O
occasions	occasion	NNS	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
BKA	BKA	NN	B-NP	B-protein
,	,	,	O	O
urosepsis	urosepsis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
confused	confuse	VBN	I-VP	O
and	and	CC	O	O
therefore	therefore	RB	B-VP	O
proved	prove	VBD	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
difficult	difficult	JJ	I-NP	O
historian	historian	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
with	with	IN	B-PP	O
radiation	radiation	NN	B-NP	O
under	under	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
4-5	4-5	CD	B-NP	O
days	day	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
denied	deny	VBD	B-VP	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
hematochezia	hematochezia	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
melena	melena	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
subjective	subjective	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
denied	deny	VBD	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
prior	prior	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
189/92	189/92	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
O2	O2	NN	I-NP	O
sat	sat	NN	I-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
finger	finger	NN	I-NP	O
stick	stick	NN	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
354	354	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
x	x	SYM	B-NP	O
three	three	CD	I-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
morphine	morphine	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
admitted	admit	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
BKA	BKA	NN	B-NP	B-protein
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
1992	1992	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
sepsis	sepsis	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
source	source	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
BKA	BKA	NN	B-NP	B-protein
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2001	2001	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
MS	MS	NN	B-NP	B-protein
Contin	Contin	NN	I-NP	I-protein
withdrawal	withdrawal	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Fibroids	Fibroid	NNS	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
C-section	C-section	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
and	and	CC	I-NP	O
dehiscence	dehiscence	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Sciatica	Sciatica	NNP	B-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
back	back	RB	I-NP	O
pain	pain	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
disc	disc	NN	B-NP	O
herniation	herniation	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
medication	medication	NN	I-NP	O
list	list	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
,	,	,	O	O
Flexeril	Flexeril	NNP	B-NP	O
,	,	,	O	O
Valium	Valium	NNP	B-NP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
significant	significant	JJ	B-NP	O
details	detail	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
positive	positive	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
cigarette	cigarette	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
say	say	VB	I-VP	O
for	for	IN	B-PP	O
how	how	WRB	B-NP	O
many	many	JJ	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
ethanol	ethanol	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
drink	drink	NN	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
illicit	illicit	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
married	married	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HPI	HPI	NN	I-NP	B-DNA
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
103.7	103.7	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
110	110	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
125/55	125/55	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
34	34	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
African	African	JJ	I-NP	O
American	American	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
confused	confuse	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x	x	NN	B-NP	O
two	two	CD	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
fruity	fruity	NN	I-NP	O
odor	odor	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
guarding	guarding	NN	I-NP	O
or	or	CC	I-NP	O
rebound	rebound	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

RECTAL	RECTAL	NNP	B-NP	O
EXAM	EXAM	NNP	I-NP	O
:	:	:	O	O
Guaiac	Guaiac	NN	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
tone	tone	NN	I-NP	O
per	per	IN	B-PP	O
ED	ED	NN	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.9	3.9	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
105	105	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
19	19	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
37	37	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
2.1	2.1	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
379	379	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.1	8.1	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.1	2.1	CD	I-NP	O
,	,	,	O	O
phosphorus	phosphorus	NN	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
33	33	CD	I-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
56	56	CD	I-NP	O
,	,	,	O	O
alk	alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
119	119	CD	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-protein
bili	bili	NNS	I-NP	I-protein
1.0	1.0	CD	B-NP	I-protein
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
13	13	CD	I-NP	I-protein
,	,	,	O	O
lipase	lipase	NN	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
14.7	14.7	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
4	4	CD	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
34.1	34.1	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
122	122	CD	B-NP	I-protein
,	,	,	O	O
PT	PT	NN	B-NP	B-cell_line
14.2	14.2	CD	I-NP	I-cell_line
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
29.1	29.1	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.3	1.3	CD	I-NP	I-protein
,	,	,	O	O
ABG	ABG	NNP	B-NP	O
T	T	NNP	I-NP	O
at	at	IN	B-PP	O
7.4	7.4	CD	B-NP	O
,	,	,	O	O
PCO2	PCO2	NN	B-NP	O
32	32	CD	I-NP	O
,	,	,	O	O
PO2	PO2	NN	B-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	O
12-35	12-35	CD	I-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
1.5	1.5	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
1.52	1.52	CD	I-NP	O
,	,	,	O	O
beta	beta	SYM	B-NP	O
hydroxybutyrate	hydroxybutyrate	NN	B-NP	O
.7	.7	CD	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
ACE	ACE	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
toxicology	toxicology	NN	I-NP	O
screens	screen	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
5.5	5.5	CD	B-NP	O
,	,	,	O	O
specific	specific	JJ	B-NP	O
gravity	gravity	NN	I-NP	O
of	of	IN	B-PP	O
1.02	1.02	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
ketones	ketone	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
bloods	blood	NNS	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	B-protein
leuk	leuk	NN	I-NP	I-protein
esterase	esterase	NN	I-NP	I-protein
and	and	CC	I-NP	O
nitrites	nitrite	NNS	I-NP	O
,	,	,	O	O
45-50	45-50	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
3-4	3-4	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
squamous	squamous	JJ	I-NP	O
epithelium	epithelium	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
beta-hCG	beta-hCG	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
cephalization	cephalization	NN	B-NP	O
and	and	CC	O	O
interstitial	interstitial	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
.5	.5	CD	B-NP	O
-1	-1	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
aVL	aVL	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
V1	V1	NN	I-NP	O
and	and	CC	I-NP	O
V2	V2	NN	I-NP	B-protein
,	,	,	O	O
flattened	flattened	JJ	B-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
aVL	aVL	NN	B-NP	O
,	,	,	O	O
V2	V2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
V3	V3	NN	B-NP	B-protein
.	.	.	O	O

SUMMARY	SUMMARY	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42-year-old	42-year-old	JJ	I-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
BKA	BKA	NN	B-NP	B-protein
on	on	IN	B-PP	O
two	two	CD	B-NP	O
prior	prior	JJ	I-NP	O
occasions	occasion	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BKA	BKA	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
systems	system	NNS	B-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
BKA	BKA	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
hydrated	hydrate	VBN	B-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	B-protein
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
escalating	escalate	VBG	B-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
up	up	RB	B-NP	O
to	to	TO	I-NP	O
65	65	CD	I-NP	O
U	U	NN	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
>	>	SYM	O	O
200	200	CD	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
coverage	coverage	NN	B-NP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
issue	issue	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
addressed	address	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
Posthydration	Posthydration	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increasing	increase	VBG	I-VP	O
respiratory	respiratory	JJ	B-NP	O
rates	rate	NNS	I-NP	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
requirements	requirement	NNS	I-NP	O
and	and	CC	O	O
rales	rale	NNS	B-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
concurrent	concurrent	JJ	B-ADJP	O
with	with	IN	B-PP	O
hydration	hydration	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
her	her	PRP	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
hypokinesis	hypokinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
enlarged	enlarge	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
mildly	mildly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
mercury	mercury	NN	B-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
putting	put	VBG	B-VP	O
her	her	PRP	B-NP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
and	and	CC	I-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
raised	raise	VBD	B-VP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
being	be	VBG	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
tachypnea	tachypnea	NN	B-NP	O
and	and	CC	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
spiral	spiral	JJ	I-NP	B-DNA
CT	CT	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
nondiagnostic	nondiagnostic	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
LENIs	LENI	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
taken	take	VBN	B-VP	O
together	together	RB	B-ADVP	O
alleviated	alleviate	VBN	B-VP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
or	or	CC	I-NP	O
DVT	DVT	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
likely	likely	RB	B-ADJP	O
had	have	VBD	B-VP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
stay	stay	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
informed	inform	VBD	B-VP	O
the	the	DT	B-NP	O
treating	treat	VBG	I-NP	O
team	team	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
using	use	VBG	I-VP	O
a	a	DT	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
machine	machine	NN	I-NP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
home	home	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inconvenience	inconvenience	NN	I-NP	O
and	and	CC	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
MICU	MICU	NN	B-NP	B-DNA
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
positive	positive	JJ	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
for	for	IN	B-PP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	O	O
her	her	PRP$	B-NP	B-cell_line
blood	blood	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	O	O
urine	urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
and	and	CC	I-NP	O
gentamycin	gentamycin	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
she	she	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
febrile	febrile	JJ	B-ADJP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
gentamycin	gentamycin	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
synergy	synergy	NN	B-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
cefotaxime	cefotaxime	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
period	period	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
take	take	VB	I-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
by	by	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
and	and	CC	I-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
peak	peak	JJ	I-NP	I-protein
CK	CK	NN	I-NP	I-protein
was	be	VBD	B-VP	O
1200	1200	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
1.52	1.52	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
normalized	normalize	VBD	B-VP	O
,	,	,	O	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
once	once	RB	B-ADVP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
was	be	VBD	B-VP	O
alleviated	alleviate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
<	<	SYM	B-NP	O
140	140	CD	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
<	<	SYM	B-NP	O
70	70	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Another	Another	DT	B-NP	O
guanosine	guanosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
exercise	exercise	VB	I-VP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
sciatica	sciatica	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
planar	planar	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
sized	sized	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
territory	territory	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
residual	residual	JJ	I-NP	O
peri-infarct	peri-infarct	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
lesion	lesion	NN	I-NP	O
warranted	warrant	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
sizable	sizable	JJ	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-NP	O
dehydration	dehydration	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
rehydrated	rehydrate	VBN	I-VP	O
and	and	CC	O	O
concurrent	concurrent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
her	her	PRP$	I-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
GI	GI	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
with	with	IN	B-PP	O
Carafate	Carafate	NNP	B-NP	O
.	.	.	O	O

Once	Once	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
p.o.	p.o.	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Carafate	Carafate	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Once	Once	RB	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
nurses	nurse	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	B-NP	O
witness	witness	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
a	a	DT	B-NP	O
stool	stool	NN	I-NP	O
sample	sample	NN	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
toxin	toxin	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
symptomatically	symptomatically	RB	B-ADVP	O
with	with	IN	B-PP	O
Imodium	Imodium	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
counseled	counsel	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Nutrition	Nutrition	NNP	I-NP	O
Service	Service	NNP	I-NP	O
regarding	regard	VBG	B-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
diabetic	diabetic	JJ	I-NP	O
and	and	CC	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

PAIN	PAIN	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
several	several	JJ	B-NP	O
pain	pain	NN	I-NP	O
medicines	medicine	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
amitriptyline	amitriptyline	NN	B-NP	O
,	,	,	O	O
Flexeril	Flexeril	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Valium	Valium	NNP	B-NP	O
for	for	IN	B-PP	O
reported	report	VBN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sciatica	sciatica	NN	B-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Neurontin	Neurontin	NN	B-NP	B-protein
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
Humulin	Humulin	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	O
65	65	CD	I-NP	O
U	U	NN	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
human	human	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
151-200	151-200	CD	B-NP	O
give	give	VBP	B-VP	O
4	4	CD	B-NP	O
U	U	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
201-250	201-250	CD	B-NP	O
give	give	VBP	B-VP	O
6	6	CD	B-NP	O
U	U	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
251-300	251-300	CD	B-NP	O
give	give	VBP	B-VP	O
8	8	CD	B-NP	O
U	U	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
301-350	301-350	CD	B-NP	O
give	give	VBP	B-VP	O
10	10	CD	B-NP	O
U	U	NN	I-NP	O
,	,	,	O	O
Imodium	Imodium	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
hrs	hr	NNS	I-NP	I-protein
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	I-NP	O
min	min	NN	I-NP	O
.	.	.	O	O

x	x	SYM	O	O
3	3	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
600	600	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
CONDITION	CONDITION	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Stable	Stable	NNP	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Prior	Prior	NN	B-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapist	therapist	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
noted	note	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
Eldsche	Eldsche	NNP	I-NP	O
St	St	NNP	I-NP	O
,	,	,	O	O
Lake	Lake	NNP	B-NP	O
Corp	Corp	NNP	I-NP	O
Ver	Ver	NNP	I-NP	O
,	,	,	O	O
Alaska	Alaska	NNP	B-NP	O
29176	29176	CD	I-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
safe	safe	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
agreed	agree	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
contact	contact	VB	B-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
with	with	IN	B-PP	O
any	any	DT	B-NP	O
concerns	concern	NNS	I-NP	O
or	or	CC	I-NP	O
questions	question	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Carmine	Carmine	NNP	I-NP	O
Guillebeau	Guillebeau	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
WNDH	WNDH	NN	B-NP	B-DNA
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
's	's	POS	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sammie	Sammie	NNP	I-NP	O
Derobertis	Derobertis	NNP	I-NP	O
of	of	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
at	at	IN	B-PP	O
Gons	Gons	NNP	B-NP	O
Landgilesnyton	Landgilesnyton	NNP	I-NP	O
Dralvail	Dralvail	NNP	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
DAMIAN	DAMIAN	NNP	B-NP	O
TABISOLA	TABISOLA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
X	X	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRODERICK	BRODERICK	NNP	B-NP	O
TURPEN	TURPEN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CV26	CV26	NNP	I-NP	O
FG399/011428	FG399/011428	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
62101	62101	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

WKKUHG9QRE	WKKUHG9QRE	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/18/01	4/18/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/18/01	4/18/01	CD	B-NP	O

